Gryphon Therapeutics

About:

Gryphon Therapeutics is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics.

Website: http://www.gryphonsci.com

Top Investors: SR One, Forward Ventures, Sprout Group

Description:

Gryphon Therapeutics is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols such as molecules to create potent medications.

Total Funding Amount:

$26M

Headquarters Location:

San Francisco, California, United States

Founded Date:

1993-01-01

Founders:

Number of Employees:

Last Funding Date:

2002-01-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai